Literature DB >> 19446107

The importance of treatment regimens and pubertal status for growth in IBD.

Mark D DeBoer, Barrett H Barnes.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19446107     DOI： 10.1016/j.jpeds.2009.01.044

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

Review 1.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin.

Authors:  Mark D Deboer; Yongli Li
Journal:  Pediatr Res       Date:  2011-01       Impact factor: 3.756

3.  Partial normalization of pubertal timing in female mice with DSS colitis treated with anti-TNF-α antibody.

Authors:  Mark Daniel Deboer; Jeremy Steinman; Yongli Li
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

Review 4.  Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains.

Authors:  Mark D DeBoer; Lee A Denson
Journal:  J Pediatr       Date:  2013-03-22       Impact factor: 4.406

5.  Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations.

Authors:  Mark D Deboer
Journal:  Int J Pept       Date:  2011-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.